临床队列临床研究Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Treatment patterns and healthcare utilization for patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) in the Veterans Health Administration (MCLOVA) who were prescribed their first Bruton Tyrosine Kinase inhibitor (BTKi): A national retrospective cohort study.
Remibrutinib是一种高选择性、强效、共价、可穿透中枢神经系统的口服BTK抑制剂。REMODEL-1和REMODEL-2为两项相同的随机、双盲、双模拟、活性对照、平行组、事件驱动Ⅲ期试验,在46个国家407个中心开展,纳入18-55岁、EDSS评分0-5.5、有近期疾病活动证据的复发型多发性硬化患者,按1:1随机接受口服remibrutinib 100 mg每日两次或特立氟胺14 mg每日一次,主要终点为年化复发率(ARR)。2021年12月13日至2025年12月30日筛查2632例,随机分配2007例;REMODEL-1纳入1000例,REMODEL-2纳入1007例。remibrutinib组ARR显著低于特立氟胺组:REMODEL-1为0.073 vs 0.112(RR 0.648,95%CI 0.453-0.927;p=0.018),REMODEL-2为0.080 vs 0.116(RR 0.688,95%CI 0.487-0.972;p=0.034)。最常见不良事件为上呼吸道感染、鼻咽炎、腹泻和脱发;导致停药的不良事件remibrutinib组较少(3.1% vs 5.8%),安全性与其他适应症一致,无肝脏安全性担忧。研究表明remibrutinib优于特立氟胺且安全性良好,支持其作为复发型多发性硬化潜在新型口服治疗选择。
Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany; Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia. Electronic address: heinz.wiendl@uniklinik-freiburg.de.
Department of Neurology, Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA.
Turku PET Centre, Clinical Neurosciences and InFLAMES Research Flagship, University of Turku, Turku, Finland; Neurocenter, Turku University Hospital, Turku, Finland.
Brigham Multiple Sclerosis Center and Division of Neuroimmunology, Mass General Brigham, Boston, MA, USA.
Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Joi Life Wellness Neurology Clinic, Smyrna, GA, USA.
Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
MedPolonia, Outpatient MS Clinic, Poznań, Poland; Department of Medical Education and Communication, Poznan University of Medical Sciences, Poznań, Poland.
Novartis Pharma, Basel, Switzerland.
Novartis Ireland, Dublin, Ireland.
Novartis Institutes for Biomedical Research, Shanghai, China.
Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain.
Oveis Jamialahmadi、Shahir Mowlaei、Kyla Z Gelev、Rosellina M Mancina、Valentina Flagiello、Julia Kozlitina、Päivi Pajukanta、Luca Valenti、Stefano Romeo
作者机构
Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Department of Medicine, Karolinska Institute, Huddinge, Sweden. oveis.jamialahmadi@ki.se.
Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Department of Medicine, Karolinska Institute, Huddinge, Sweden.
Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy.
Operative Research Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
The Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, USA.
Institute for Precision Health, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Precision Medicine and Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milan, Italy.
Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Department of Medicine, Karolinska Institute, Huddinge, Sweden. stefano.romeo@ki.se.
Department of Endocrinology, Karolinska University Hospital, Huddinge, Sweden. stefano.romeo@ki.se.
Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy. stefano.romeo@ki.se.
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. stefano.romeo@ki.se.
Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden. stefano.romeo@ki.se.
技术路线
MRI衍生肝脏甘油三酯含量数据(71,488名欧洲 ancestry UK Biobank参与者)→全基因组关联研究荟萃分析→识别60个独立位点(31个新位点)并估计SNP遗传力为25%→整合精细定位与基因优先级分析提名48个位点的候选效应基因→在临床诊断的代谢功能障碍相关脂肪性肝病荟萃分析(42,163例病例和1,646,254例对照)中验证31个新位点中的14个→多基因风险评分与肝硬化(OR 2.71)和肝细胞癌(OR 7.47)风险关联分析→与多基因风险评分相关的血浆蛋白通路富集分析(代谢重塑和炎症通路,肝脏富集蛋白特征增加、内脏脂肪特征减少)
Tamrin Chowdhury、C Mircea S Tesileanu、Emre Kocakavuk、Kevin C Johnson、Joo Ho Lee、Zeynep Erson-Omay、Chaewon Heo、Kenneth Aldape、Samirkumar B Amin、Kevin J Anderson、David M Ashley、Floris P Barthel、Jill S Barnholtz-Sloan、Daniel J Brat、Andrew R Brodbelt、Ana Valeria Castro、Elizabeth B Claus、Jennifer M Connelly、Joseph F Costello、Indrani Datta、Carol Elliott、Gaetano Finocchiaro、Pim J French、Hui K Gan、Luciano Garofano、Padmaja L Ghospurkar、Anna Golebiewska、Pranav S Gundla、Beth Hermes、Chibo Hong、Youri Hoogstrate、Craig Horbinski、Jason T Huse、Antonio Iavarone、Cihat Karadag、Mustafa Khasraw、Mathilde C M Kouwenhoven、Peter S LaViolette、Kay Li、Allison Lowman、Katy McCortney、Hyo-Eun Moon、Nader Sanai、MacLean P Nasrallah、H K Ng、D Ryan Ormond、Bethany Kwan、Marta Padovan、Sun Ha Paek、Laila M Poisson、Sushant Puri、Erica Shen、Shwetal Mehta、Andrew E Sloan、Wies R Vallentgoed、Erwin G Van Meir、Rachael Vaubel、Taylor E Wade、Annemiek M E Walenkamp、Colin Watts、Tobias Weiss、Michael Weller、Pieter Wesseling、Kerryn Westcott、Bart A Westerman、Gordon Y Ye、W K Alfred Yung、GLASS Consortium、Frederick S Varn、Roel G W Verhaak
作者机构
Department of Neurosurgery, Yale University, New Haven, CT, USA.
Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), National Center for Tumor Diseases (NCT) West, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
National Institutes of Health, Bethesda, MD, USA.
The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Preston Robert Tisch Brain Tumor Center at Duke University, Durham, NC, USA.
Translational Genomics Research Institute, Phoenix, AZ, USA.
National Cancer Institute, Bethesda, MD, USA.
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Walton Centre NHS Foundation Trust, Liverpool, UK.
Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Health, Detroit, MI, USA.
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.
Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.
St Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Department of Neurology, IRCCS Ospedale San Raffaele, Milan, Italy.
Department of Neurology, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Cancer Therapies and Biology Laboratory, Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Victoria, Australia.
Department of Public Health Sciences, Division of Biostatistics and Bioinformatics, Miller School of Medicine, University of Miami, Miami, FL, USA.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Department of Neurology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Pathology, Prince of Wales Hospital, Hong Kong, China.
Department of Neurosurgery, Cancer Research Institute, Hypoxia/Ischemia Disease Institute, Seoul National University, Seoul, Republic of Korea.
Ivy Brain Tumor Center at the Barrow Neurological Institute, Phoenix, AZ, USA.
Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Neurosurgery, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Department of Emergency Medicine, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Advanced Institutes of Convergence Technology, Seoul National University, Suwon-si, Republic of Korea.
Oregon Health & Science University, Portland, OR, USA.
Neurological Institute, Premier Health and Wright State University School of Medicine, Dayton, OH, USA.
University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Cancer Genome Sciences, University of Birmingham, Birmingham, UK.
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
VUmc, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Neurosurgery, VUmc, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
University of California, San Diego, La Jolla, CA, USA.
Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. frederick.varn@jax.org.
Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, CT, USA. frederick.varn@jax.org.
Institute for Systems Genomics, University of Connecticut, Storrs, CT, USA. frederick.varn@jax.org.
Department of Neurosurgery, Yale University, New Haven, CT, USA. roel.verhaak@yale.edu.
MacLean C Sellars、Jessica A Frank、Bohoon Shim、Allison Vanasse、Ruolin Liu、Cleo Forman、Chloe R Tu、Kyohei K Tabata、Antonia Kowelewski、Su-Chun Cheng、Catherine Song、Kan Xiong、Pia Jain、Andjela Crnjac、Haley E Sax、Vipheaviny Chea、Wesley Lu、J Thomas Janes、Micah Rickles-Young、Amit Sud、Savni Sarolkar、Martin Hayes、Oriol Olive、Haley Greenslade、Carrie Cibulskis、Nir Hacohen、Edward F Fritsch、Shuqiang Li、Kenneth J Livak、Nabihah Tayob、Elizabeth H Stover、Carolyn Krasner、Rebecca Porter、Ursula Matulonis、Gad Getz、Giacomo Oliveira、Patrick A Ott、Jeremy M Simon、Viktor A Adalsteinsson、Derin B Keskin、Panagiotis A Konstantinopoulos、Catherine J Wu
作者机构
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Department of Pathology, Harvard Medical School, Boston, MA, USA.
Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Department of Medical Education and Biomedical Sciences, Methodist University CFVH School of Medicine, Fayetteville, NC, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Panogiotis_Konstantinopoulos@dfci.harvard.edu.
Harvard Medical School, Boston, MA, USA. Panogiotis_Konstantinopoulos@dfci.harvard.edu.
Mellen and Eisenson Family Center for BRCA and Related Genes, Dana-Farber Cancer Institute, Boston, MA, USA. Panogiotis_Konstantinopoulos@dfci.harvard.edu.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Catherine_Wu@dfci.harvard.edu.
Harvard Medical School, Boston, MA, USA. Catherine_Wu@dfci.harvard.edu.
Broad Institute of MIT and Harvard, Cambridge, MA, USA. Catherine_Wu@dfci.harvard.edu.
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Catherine_Wu@dfci.harvard.edu.
为什么值得关注
暂未整理